NCT04751877
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- CHU Poitiers Poitiers, France
Clinical trial condition
Multiple Myeloma
Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.
1,661 public trials
325 recruiting studies
Multiple Myeloma trial results
Active, Not Recruiting
Daratumumab, VELCADE (Bortezomib), Lenalidomide and Dexamethasone Compared to VELCADE, Lenalidomide and Dexamethasone in Subjects With Previously Untreated Multiple Myeloma
NCT03710603
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Alfred Hospital Melbourne, Australia
- University Hospital Leuven Leuven, Belgium
- University Hospital Ostrava Ostrava, Czechia
- Odense University Hospital Odense, Denmark
Active, Not Recruiting
A Study of TNB-383B in Participants With Relapsed or Refractory Multiple Myeloma
NCT03933735
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- University of California San Francisco (UCSF) - Parnassus Heights /ID# 238680 San Francisco, California, United States
- Tulane University School of Medicine /ID# 242322 New Orleans, Louisiana, United States
- Mayo Clinic - Rochester /ID# 238683 Rochester, Minnesota, United States
- Washington University-School of Medicine /ID# 238681 St Louis, Missouri, United States
Active, Not Recruiting
UARK 2006-66, Total Therapy 3B: An Extension of UARK 2003-33 Total Therapy
NCT00572169
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- University of Arkansas for Medical Sciences/Myeloma Institute Little Rock, Arkansas, United States
Active, Not Recruiting
Trial on the Effect of Isatuximab to Lenalidomide/Bortezomib/Dexamethasone (RVd) Induction and Lenalidomide Maintenance in Patients With Newly Diagnosed Myeloma (GMMG HD7)
NCT03617731
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Uniklinik RWTH Aachen, Klinik für Hämatologie, Onkologie, Hämostaseologie und Stammzelltransplantation Aachen, Germany
- Helios Klinikum Bad Saarow, Klinik für Hämatologie, Onkologie und Palliativmedizin Bad Saarow, Germany
- Charité, Campus Benjamin Franklin , III. Medizinische Abteilung (Hämatologie/Onkologie) Berlin, Germany
- Vivantes Klinikum Neukölln, Klinik für Hämatologie und Onkologie Berlin, Germany
Active, Not Recruiting
Study of Daratumumab Combined With Carfilzomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma
NCT04113018
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Levine Cancer Institute Charlotte, North Carolina, United States
Active, Not Recruiting
Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65
NCT01208662
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Arizona Comprehensive Cancer Center Tucson, Arizona, United States
- City of Hope Duarte, California, United States
- University of California at San Diego La Jolla, California, United States
Active, Not Recruiting
A Study of Elotuzumab With Pomalidomide, Bortezomib, and Dexamethasone in Relapsed Multiple Myeloma
NCT02718833
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
- Locations
-
- Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Mass General/North Shore Cancer Center Danvers, Massachusetts, United States
- Newton-Wellesley Hospital Newton, Massachusetts, United States
Active, Not Recruiting
A Study of the Combination of Talquetamab and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
NCT04586426
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- University of Alabama at Birmingham, Comprehensive Cancer Center Birmingham, Alabama, United States
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- Colorado Blood Cancer Institute Denver, Colorado, United States
- Emory University Atlanta, Georgia, United States
NCT03246529
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- UCLA Medical Center Los Angeles, California, United States
- University of Florida Gainesville, Florida, United States
- University of Miami Miami, Florida, United States
- Loyola University Medical Center Chicago, Illinois, United States